These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 307735)

  • 1. [Ischemia of the extremities caused by a combination of dihydroergotamine and triacetyloleandomycin. New case report].
    Bacourt F; Couffinhal JC
    Nouv Presse Med; 1978 May; 7(18):1561. PubMed ID: 307735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dihydroergotamine and triacetyloleandomycin combination. Its role in iatrogenic necrosis of the fingers].
    Vayssairat M; Fiessinger JN; Bequemin MH; Housset E
    Nouv Presse Med; 1978 Jun; 7(23):2077. PubMed ID: 307740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute ergotism caused by dihydroergotamine-triacetyloleandomycin association].
    Franco A; Bourlard P; Massot C; Lecoeur J; Guidicelli H; Bessard G
    Nouv Presse Med; 1978 Jan; 7(3):205. PubMed ID: 307229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Risk of arterial vasospasms caused by the administration of dihydroergotamine (Dihytamin)--a case report].
    Lange T
    Anaesthesiol Reanim; 1987; 12(3):177-81. PubMed ID: 3620072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ergotamine-induced disorders of the peripheral blood circulation--a case report].
    Creutzig A; Kamin K; Flöge J; Wannske M; Alexander K; Wagner HH
    Rontgenblatter; 1985 Jun; 38(6):193-5. PubMed ID: 4023577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiospasm and dihydroergotamine--dangers in thromboprevention].
    Schwering H; Rühland D
    Zentralbl Chir; 1985; 110(18):1115-21. PubMed ID: 4082802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk of combination of tri-acetyl-oleandomycin and ergotamine tartrate].
    Lesca H; Ossard D; Reynier P
    Nouv Presse Med; 1976 Sep; 5(29):1832-3. PubMed ID: 1085925
    [No Abstract]   [Full Text] [Related]  

  • 8. Lower-limb vasospasm and renal failure during postoperative thromboprophylaxis. Case report.
    Mattsson E; Ohlin A; Balkfors B; Fredin HO; Nilsson P; Bergqvist D
    Eur J Surg; 1991 Apr; 157(4):289-92. PubMed ID: 1677286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is triacetyl oleandomycin-ergotamine tartrate combination dangerous?].
    Bigorie B; Aimez P; Soria RJ; Samama F; di Maria G; Guy-Grand B; Bour H
    Nouv Presse Med; 1975 Nov; 4(38):2723-5. PubMed ID: 1081686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications in the treatment of migraine with ergotamine and its derivatives].
    Durko A; Głuszcz-Zielińska A
    Wiad Lek; 1981 May; 34(9):779-83. PubMed ID: 7281680
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute iatrogenic ergotism by drug association. Diagnosis through non-invasive exploration (Doppler velocimetry (author's transl)].
    Chignier E; Riou R; Descotes J; Meunier P; Courpron P; Vignon G
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2478. PubMed ID: 308639
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydroergotamine-associated intestinal ischemia in a child with cyclic vomiting syndrome.
    Padon A; Ostadian M; Wright C; Pohl J; Crisp D; Easley D
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):573-5. PubMed ID: 16707983
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complications in drug prevention of thromboembolism].
    Tittel K
    Unfallchirurgie; 1985 Jun; 11(3):150-5. PubMed ID: 4035815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ergotism of the lower extremities resulting from thrombosis prevention using DHE-heparin. An angiographic follow-up study].
    Warmuth-Metz M
    Radiologe; 1988 Oct; 28(10):491-3. PubMed ID: 3186973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
    Schott G; Riedel K
    Zentralbl Chir; 1986; 111(21):1354-7. PubMed ID: 3101315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial spasm caused by administration of DHE-heparin in a tibial fracture].
    Hertz H; Wruhs O; Polterauer P
    Aktuelle Traumatol; 1984 Aug; 14(4):142-5. PubMed ID: 6147974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute ischemia of the extremities: apropos of a case of ergotamine tartrate poisoning].
    Ibáñez Esquembre V; Collado G; González Ríos J; Masegosa A; Cabrera Garrido AL
    Angiologia; 1986; 38(6):315-9. PubMed ID: 3099606
    [No Abstract]   [Full Text] [Related]  

  • 20. Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparin.
    Shackford SR; Davis JW
    Crit Care Med; 1988 Sep; 16(9):909-10. PubMed ID: 3402234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.